{"name":"I-Mab Biopharma US Limited","slug":"i-mab-biopharma-us-limited","ticker":"","exchange":"","domain":"imabus.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9iVUFUYkF6aGt3akxZT0hGaW1LLTVITDlQdFFCYUZkc2IwaDJKSHZpQ1d2VmtPWldraV9yWm9idUZab0xqcWZzdXllQ1BIaF9WUGVxcFJMNWhPakFld2QzRVg2dElTbkZjVjdzcEY3QmtFRG96SzhTT25aMkY?oc=5","date":"2025-12-17","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Layoff Tracker 2025: Voyager jettisons 30 staffers; Mythic and Areteia shutter - Fierce Biotech","headline":"Fierce Biotech Layoff Tracker 2025: Voyager jettisons 30 staffers; Mythic and Areteia shutter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPQ0IyRmpWZzhoSnhlMVFEdVdtRzM2TjRtN0FfSXp5YjBSMHJVcGZwNlJxR09OODhWQWhIM3NRcV9pdEczQUhiaEs1aXpXYVlRWFlWb1k5QVVfd0t5bmQxRmVGblpDZVM4SmRtN2taaExmRU9KN3BmLU95bVRRM1V4aWtYaEZQVGpZNzRsOEVrSTdVc2FiVTFDcDJhb19DczA5M2IzM0FR?oc=5","date":"2025-12-09","type":"pipeline","source":"BioWorld News","summary":"73 Chinese biotech, med-tech companies file for HK IPOs in 2025 - BioWorld News","headline":"73 Chinese biotech, med-tech companies file for HK IPOs in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQRkRGX2dKSm9NV3M4YTNwcjZ0VkUzZFRZVF8tdDVHNDhhY3FPYnZ2ZWVuWC1CcVZrWGxBZ1BCWng3dXZ3NVJkUDAwa3p5eHBjSnRrVXd6dFJRT04yeVU3aVJqMTJQSVpBaGZLbGpkZERUdjJmdG1jTDdBNUQzRXBzU3pRMjNJc20xeExvTDQyTXJUQVZRcUJBeDRB?oc=5","date":"2025-11-05","type":"pipeline","source":"BioWorld News","summary":"Neok Bio launches with $75M to develop bispecific ADCs - BioWorld News","headline":"Neok Bio launches with $75M to develop bispecific ADCs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gJBVV95cUxQZTFIRE9TVEZfMXVjcGplRzFzT2k4TUJKNTRXMVlaS3M0RVVxeWh5QThnTnRDSEpPYlBhNnpLNEVkM2YwemhxUlFVNzM2aVpJaW84ODJVT2ZFWnlrSE9PNGJxZVp6X3hZZ0dNNkY0SWQ5ZEFWdHlQcU5JeTJTTklmLTRzSFRyRFhWWTJHcGxYT3ZINlY4YjJqUS1nU2lveGxhQm0zdE9UOS16MElENTBEaHM1RG1ORC1xRjBzVUJDSzRCRi1lTzhIWDFIcnRqMm4xWVRDbzFiTXprTVhvNUlCS3k0bmJ5a3RCUnhHWHY2V1lyZTEyWEptcHBISHhjRDFDODlsLUVWSXlWNkRoQVR1MWYwMVhVazRPQUJfWE9RTjJFclhvSThkdGVVNUkzdzJYQjBaUlJVdF9xakNwZ3k2LXRXVnhTdWtzRGpnbWV3aGl1alphbE8yblFpRW5tMGpNeG05RFpLTUNLUQ?oc=5","date":"2025-10-29","type":"pipeline","source":"PR Newswire","summary":"I-MAB (Nasdaq: IMAB) Transitions to NovaBridge Biosciences (Nasdaq: NBP) with Trading Effective October 30, 2025 New Brand and Logo to Reflect Strategic Transformation to a Global Biotech Platform - P","headline":"I-MAB (Nasdaq: IMAB) Transitions to NovaBridge Biosciences (Nasdaq: NBP) with Trading Effective October 30, 2025 New Bra","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQQUlaRUJ3MG0zRGJfR2IwRkYyOVYtM3VOOV84bk1OaG5DNGNKbzZIcjBPeVI3cGJEXzBFd1o4dXJ5YTlKWS1sSTlBTDdLRUxNLWJyMXh1SG1UV2JtZlFlODh2WU1uZEZEbC1Ia0hHZlUzZEF5TFZOckNUQVUtSWFNaHBfbXgyOWxNQUFIXzdaQWtzUUlleGR6cllhdXlWYWo2eEtlcGNWZ2NUaS1UWmpF?oc=5","date":"2025-10-17","type":"pipeline","source":"Fierce Biotech","summary":"I-Mab undergoes makeover, with new name, strategy, asset and Hong Kong IPO plans - Fierce Biotech","headline":"I-Mab undergoes makeover, with new name, strategy, asset and Hong Kong IPO plans","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQa0Z3bTNlZUFPVFhsU0o0RnFLSTRTQmhHSG4tRzBLS3Z1VkszeW9YNTdoVDc5M0xLZDlRVTNXcGtPWHhUd2pKdVBiZ0FwQWV0QU5HSEVyU2JKYmRjZnE0Q0FvSVFkLVNOVnd0ejlLWVZGc0RVTkRhWU5IVHRJQ0NlMUZBd1Rqal9aUVFVRFAtUQ?oc=5","date":"2025-08-01","type":"pipeline","source":"Contract Pharma","summary":"Everest Medicines Invests $30.9M in I-Mab - Contract Pharma","headline":"Everest Medicines Invests $30.9M in I-Mab","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOYUFoam1lNXdJSjNJcEhCaVRyenQxMzdBV2lZbTA0UHA1QlZUZXNGUGJOUVhpcElWOENCYnY2NGZVdkJIRWV4OW1NVFdwNHY3Z1FtRGczYmJtTUp1YThvc0xOS3lQZ2J5ODdacTE2QUItQ0Z1elJfQWJGZ1l5dFZwcVZFbHR6eG9LSkZsWXZsS01UOEJoakFqQ1BNZ1k1RFo3T1VDeVVkallYUQ?oc=5","date":"2025-05-18","type":"pipeline","source":"bioprocessintl.com","summary":"CDMO Piramal Pharma bolsters US footprint with $90m facility expansion - bioprocessintl.com","headline":"CDMO Piramal Pharma bolsters US footprint with $90m facility expansion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxQVVdPV1Q1Tmd1dWRzYmRaXzJ2bGVaMVlhR3ZVRFZKOE50Z01fTGlKZVpjMXI3ODFCSElaaVZnYWJ6TGdyR19mbXBBZzVidVpZSkc2Wk5qS0RBd1hoamRSZExsdllZdDVkZFNOT1c2aGxHZ0U1ckw2TlktRDNsRkpMb2FiZ2tIRTdZWi1RTktXSU54bTZDVndNSW5FcFBZcmZCdEVCZmp1czJTZkd1R1dBMldZN3QwRnFlM1J1VFBvNDR1T3RJaHUzcm1aaw?oc=5","date":"2025-01-08","type":"pipeline","source":"BioSpace","summary":"I-Mab Announces Open Market Purchases of Company American Depositary Shares by Board Member - BioSpace","headline":"I-Mab Announces Open Market Purchases of Company American Depositary Shares by Board Member","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE16eElydlRVSzI3NXRQX3ZfODdSMlhacG1XUG5fS1FrUmd0ZTB5VzZEMkJNU3JPZjRIelZZc2FFY1BpSGh1WnczbnhmZWxmNDlNVEx3?oc=5","date":"2025-01-06","type":"pipeline","source":"FirstWord Pharma","summary":"I-Mab shuffles pipeline, pauses CD73 programme post-Sanofi pact - FirstWord Pharma","headline":"I-Mab shuffles pipeline, pauses CD73 programme post-Sanofi pact","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPUDV6bTJHN3VrdEp0S0thcWRkMDdRcmkwclphUFNnN3RmWVVQYVF6OFBZNnZDRFBsdTA2NEp6dGtuX3hyc3Z6c0MxOE53YlhSMEFTS0FfNXYxNGl3eTZWVEVYVFRwaHhhbEltQ2VTc05VSkZxMDRJLTBSVDR6ank2Y3JvT3ZQWTJzZ285SDBuXzBheU1hendIWnQwNXc0X0NYdGZHUGRn?oc=5","date":"2024-08-28","type":"pipeline","source":"BioSpace","summary":"I-Mab Reports 1H 2024 Financial Results, Pipeline Progress, and Business Updates - BioSpace","headline":"I-Mab Reports 1H 2024 Financial Results, Pipeline Progress, and Business Updates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxORjN0WVR2SU9KcnRvbW43dFJkc24wUlBNM0xYdGVJVE9KdHV4eUpMYlBqd3BGamRPYTR3bWlPMXBRRDVaMTNWTXMyajBQSTFhSE5IaUZreEpFc25FQjVEbkJzNmVBUENpMkdfcFlLaElHdkZ5MGxDaEZsVHExV1BwRDFDTzNScU4xdndjRF9JaEE2emhCLTIzcGlIUDJRcjAtTTQ2TDk3cGRXWFpYWms5OWx4SUFVa3REY3ZpekFyQkxJbXFPMFkzcVI0UQ?oc=5","date":"2024-02-07","type":"pipeline","source":"PR Newswire","summary":"I-Mab Signs Agreement to Divest its Assets and Business Operations in China - PR Newswire","headline":"I-Mab Signs Agreement to Divest its Assets and Business Operations in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE0yeWxPcGR0dHhDcDJJNlhBZmRFMXFsaGhvTmJjUGMtSG5tS0l1dzl2MFNkZW5SZnBLekFvQUhaczhWNmF5Ymk5SGRHWUMzWktOWlh6a3dpUGlNSndYd3dKVw?oc=5","date":"2023-10-27","type":"deal","source":"复宏汉霖","summary":"Henlius Deepens Collaboration with Intas to bring Henlius’ Novel anti-PD-1 mAb Serplulimab to Europe and India - 复宏汉霖","headline":"Henlius Deepens Collaboration with Intas to bring Henlius’ Novel anti-PD-1 mAb Serplulimab to Europe and India - 复宏汉霖","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}